☆ 4.5 Article

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model

RESPIRATORY RESEARCH (2022)

Related references

Note: Only part of the references are listed.

Article Respiratory System

Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis

Koichi Miyashita et al.

Summary: Acute exacerbation (AE) has a severe impact on idiopathic pulmonary fibrosis (IPF) but its effects on other types of fibrotic interstitial lung disease (ILD) are unclear. Research suggests that ILD other than IPF may have a better prognosis after AE, but both conditions can lead to chronic respiratory failure.

CLINICAL RESPIRATORY JOURNAL (2021)

Add to Collection

Article Rheumatology

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: clinical features and prognosis

Shinji Izuka et al.

Summary: This study retrospectively analyzed the clinical characteristics and risk factors of ILD-AE in 165 RA-ILD patients. The results showed a significant association between the UIP pattern and the occurrence of ILD-AE and mortality.

RHEUMATOLOGY (2021)

Add to Collection

Article Critical Care Medicine

Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis

Hironao Hozumi et al.

Summary: This study found that MPA-ILD represents a distinct phenotype with poor prognosis. A lower %FVC was identified as an independent prognostic factor, associated with increased mortality and risk of developing AE in MPA-ILD patients. Specific management strategies for MPA-ILD and AE should be established in the future.

CHEST (2021)

Add to Collection

Article Multidisciplinary Sciences

Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study

Takahito Suzuki et al.

Summary: This study investigated prognostic factors for acute exacerbation in IPF patients and developed prognostic classification models. The models based on baseline lung function and oxygenation indices can categorize patients into different severity groups, guiding clinical decision-making and aiding in the design of future studies on AE-IPF.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Respiratory System

A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease

Hiroyuki Kamiya et al.

Summary: Acute exacerbation of systemic autoimmune disease-associated interstitial lung disease is not uncommon and has a poor prognosis. Age at initial presentation and %DLCO are considered risk factors, while PaO2/FiO2 at exacerbation is seen as a prognostic factor of the disease.

BMC PULMONARY MEDICINE (2021)

Add to Collection

Review Respiratory System

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management

Suha Kadura et al.

Summary: Rheumatoid arthritis (RA) is a systemic inflammatory disorder, with lung involvement being the most common extra-articular manifestation. RA-ILD is a leading cause of death in RA patients with significant morbidity and mortality. Rational clinical approaches for the diagnosis and management of RA-ILD are discussed, along with future directions for research in RA-associated lung disease.

EUROPEAN RESPIRATORY REVIEW (2021)

Add to Collection

Article Respiratory System

Rheumatoid Arthritis and Associated Interstitial Lung Disease Mortality Rates and Trends

Niranjan Jeganathan et al.

Summary: The mortality rates of rheumatoid arthritis (RA) and RA-associated interstitial lung disease (RA-ILD) vary by demographics, with higher rates in women and older age groups. Overall, RA-related mortality rates are decreasing, while RA-ILD-related mortality rates remain stable.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Add to Collection

Article Respiratory System

Acute exacerbations of fibrotic interstitial lung diseases

Atsushi Suzuki et al.

RESPIROLOGY (2020)

Add to Collection

Article Health Care Sciences & Services

Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View

Norimichi Akiyama et al.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2020)

Add to Collection

Article Medicine, General & Internal

Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis

Hiroyuki Kamiya et al.

BMJ OPEN (2020)

Add to Collection

Article Respiratory System

Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases

Johanna Salonen et al.

BMJ OPEN RESPIRATORY RESEARCH (2020)

Add to Collection

Article Medicine, Research & Experimental

The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease

Joshua J. Solomon et al.

ADVANCES IN THERAPY (2019)

Add to Collection

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Critical Care Medicine

Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Add to Collection

Article Respiratory System

Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis

Noriyuki Enomoto et al.

CHRONIC RESPIRATORY DISEASE (2018)

Add to Collection

Review Respiratory System

Acute exacerbations of progressive-fibrosing interstitial lung diseases

Martin Kolb et al.

EUROPEAN RESPIRATORY REVIEW (2018)

Add to Collection

Article Rheumatology

Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease

Mineto Ota et al.

MODERN RHEUMATOLOGY (2017)

Add to Collection

Review Critical Care Medicine

Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Add to Collection

Article Rheumatology

Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study

Mitsuhiro Akiyama et al.

RHEUMATOLOGY INTERNATIONAL (2016)

Add to Collection

Article Medicine, General & Internal

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study

Hironao Hozumi et al.

BMJ OPEN (2013)

Add to Collection

Article Respiratory System

Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic

Ryo Tachikawa et al.

RESPIRATION (2012)

Add to Collection

Article Respiratory System

Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Outcome and Prognostic Factors

Virginie Simon-Blancal et al.

RESPIRATION (2012)

Add to Collection

Article Rheumatology

2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

Daniel Aletaha et al.

ARTHRITIS AND RHEUMATISM (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases

Takafumi Suda et al.

RESPIRATORY MEDICINE (2009)

Add to Collection

Article Critical Care Medicine

Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis

I-Nae Park et al.

CHEST (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.